Impact of COVID-19 on New – onset Type 1 diabetes mellitus: A six-year retrospective review from two Paediatric clinics, Kampala, Uganda
PLOS One · 2026
DOI: 10.1371/journal.pone.0341145 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Rosemary Ahabwenki und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of pediatrics and child health, school of medicine, college of health sciences, Makerere university, Kampala, Uganda. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, COVID-19. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Type 1 Diabetes Mellitus is one of the most common chronic diseases in children, yet data from low-income countries remains scarce. Recent reports suggest a rising global incidence of new-onset T1DM, projected to double by 2045. The COVID-19 pandemic is believed to have further influenced T1DM onset and severity at presentation, with several studies reporting increased incidence and higher rates of diabetic ketoacidosis (DKA). This study aimed to assess the impact of COVID-19 pandemic on paediatric type 1 diabetes mellitus onset.
Methods
We conducted a retrospective review of medical records for children aged 6 months to 19 years diagnosed with new-onset T1DM between March 2017 and February 2023 at Mulago and Nsambya hospital’s paediatric diabetes clinics. Clinical and demographic characteristics were compared between the pre-COVID- 19 (March 2017–February 2020) and COVID-19 (March 2020–February 2023) periods using Chi-square and Fisher’s exact tests. Trends in new onset type 1 diabetes were analyzed using interrupted time series with 12 six-month intervals. STATA 17.0 was used for the analysis.
Results
A total of 245 children were included. The mean age at diagnosis was 10.9 years (SD ± 4.5), with 56% being female. More cases were diagnosed during the COVID-19 period (60.4%, n = 148) compared to the pre-COVID-19 period (39.6%, n = 97), representing a 52% increase, although it was not statistically significant (p = 0.1997). Overall, 66% (n = 162) presented with DKA at diagnosis, with similar proportions in both periods (pre-COVID: 61%, COVID-19: 69%).
Conclusion
There was a rising trend in T1DM among Ugandan children at Mulago and Nsambya pediatric diabetic clinics, from 2.7 new cases/month during pre-COVID to 4.1/month during the pandemic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of pediatrics and child health, school of medicine, college of health sciences, Makerere university, Kampala, Uganda.
- Department of Pediatrics and child health, St. Francis Hospital Nsambya, Kampala, Uganda.
- Infectious Diseases Research Collaboration (IDRC), Kampala, Uganda.
ORCID-Profile: Rosemary Ahabwenki, Robert Kidega
Zitieren
APA
Ahabwenki, R., Piloya, T., Namiiro, F., Muzeyi, W., Nyangabyaki, C., Katairo, T., Namugumya, A., Nakimera, J., Kyekulidde, F., Kidega, R., Ali, F. N., Mirembe, A., Kikaire, B., Ndeezi, G., Musiime, V., & Kiguli, S. (2026). Impact of COVID-19 on New – onset Type 1 diabetes mellitus: A six-year retrospective review from two Paediatric clinics, Kampala, Uganda. PLOS One. https://doi.org/10.1371/journal.pone.0341145
Vancouver
Ahabwenki R, Piloya T, Namiiro F, Muzeyi W, Nyangabyaki C, Katairo T, et al. Impact of COVID-19 on New – onset Type 1 diabetes mellitus: A six-year retrospective review from two Paediatric clinics, Kampala, Uganda. PLOS One. 2026. doi:10.1371/journal.pone.0341145
BibTeX
@article{Ahabwenki2026,
author = {Ahabwenki, Rosemary and Piloya, Thereza and Namiiro, Flavia and Muzeyi, Wani and Nyangabyaki, Catherine and Katairo, Thomas and Namugumya, Aidah and Nakimera, Joan and Kyekulidde, Fred and Kidega, Robert and Ali, Fozia Nizar and Mirembe, Angella and Kikaire, Bernard and Ndeezi, Grace and Musiime, Victor and Kiguli, Sarah},
title = {Impact of COVID-19 on New – onset Type 1 diabetes mellitus: A six-year retrospective review from two Paediatric clinics, Kampala, Uganda},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0341145}
}
EUVIMED